Table 2.

Multivariate analysis for humoral response and T-cell response.

Multivariate analysis for humoral response
	Odds ratio (95% CI)	P value
Age (≥69 years versus <69 years)	0.529 (0.244–1.15)	0.11
Patient gender (male versus female)	0.343 (0.153–0.767)	0.009
BMI (>25 versus ≤25 kg/m2)	1.730 (0.803–3.710)	0.16
Diagnosis (lymphoid versus myeloid malignancy)	0.765 (0.329–1.780)	0.53
Current treatment (yes versus no)	0.646 (0.238–1.750)	0.39
Anti-B-cell treatment in the previous 12 months (yes versus no)	0.231 (0.081–0.658)	0.006
CD19+ B cells (≥120/μL versus <120/μL)	0.260 (0.111–0.609)	0.002

Multivariate analysis for T-cell response
	Odds ratio (95% CI)	P value
Age (≥69 years versus <69 years)	0.965 (0.313–2.980)	0.95
Patient gender (male versus female)	0.476 (0.150–1.510)	0.21
BMI (>25 versus ≤25 kg/m2)	1.580 (0.542–4.640)	0.40
Diagnosis (lymphoid versus myeloid malignancy)	1.240 (0.339–4.510)	0.75
Current treatment (yes versus no)	0.175 (0.046–0.674)	0.011
Anti-B-cells treatment in the previous 12 months (yes versus no)	3.110 (0.713–13.500)	0.13
CD3+ T cells (≥850/μL versus <850/μL)	2.880 (0.889–9.320)	0.078